Dimensional Fund Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $246K | Hold |
|
|||||
|
2023
Q4 | $133K | Sell |
|
|||||
|
2023
Q3 | $222K | Sell |
|
|||||
|
2023
Q2 | $1.14M | Sell |
|
|||||
|
2023
Q1 | $1.89M | Sell |
|
|||||
|
2022
Q4 | $2.75K | Sell |
|
|||||
|
2022
Q3 | $10.3M | Buy |
|
|||||
|
2022
Q2 | $8.29M | Buy |
|
|||||
|
2022
Q1 | $8.53M | Buy |
|
|||||
|
2021
Q4 | $7.68M | Buy |
|
|||||
|
2021
Q3 | $5.08M | Buy |
|
|||||
|
2021
Q2 | $2.52M | Sell |
|
|||||
|
2021
Q1 | $4.21M | Buy |
|
|||||
|
2020
Q4 | $2.15M | Buy |
|
|||||
|
2020
Q3 | $771K | Buy |
|
|||||
|
2020
Q2 | $223K | Buy |
|